Labcorp Holdings Files 8-K on Definitive Agreement

Ticker: LH · Form: 8-K · Filed: 2025-01-31T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, 8-k

Related Tickers: LH

TL;DR

Labcorp just filed an 8-K for a material definitive agreement and financial obligation. Big moves ahead.

AI Summary

On January 31, 2025, LABCORP HOLDINGS INC. filed an 8-K report detailing a material definitive agreement and the creation of a direct financial obligation. The filing also included financial statements and exhibits.

Why It Matters

This filing indicates Labcorp Holdings Inc. has entered into a significant agreement that may impact its financial obligations and operations.

Risk Assessment

Risk Level: medium — The filing concerns a material definitive agreement and financial obligations, which inherently carry financial and operational risks.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement?

The filing indicates the entry into a material definitive agreement but does not specify its details within the provided text.

What is the direct financial obligation being reported?

The filing states the creation of a direct financial obligation but does not provide specific details on the obligation itself.

What financial statements and exhibits are included with this filing?

The filing mentions that financial statements and exhibits are included, but their specific content is not detailed in the provided text.

When was LABCORP HOLDINGS INC. incorporated?

LABCORP HOLDINGS INC. was incorporated in Delaware.

What is the principal executive office address for LABCORP HOLDINGS INC.?

The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

From the Filing

0000920148-25-000017.txt : 20250131 0000920148-25-000017.hdr.sgml : 20250131 20250131172007 ACCESSION NUMBER: 0000920148-25-000017 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250131 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250131 DATE AS OF CHANGE: 20250131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 25579485 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20250131.htm 8-K lh-20250131 0000920148 false 0000920148 2025-01-31 2025-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 31, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 31, 2025, Labcorp Holdings Inc. (the “Company”) amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the First Amendment to the Receivables Purchase Agreement (the “RPA Amendment”), among Labcorp Receivables LLC (“Labcorp Receivables”), Laboratory Corporation of America Holdings, PNC Bank, National Association, as administrative agent and the other parties party thereto and acknowledged and agreed by the Company. Pursua

View on Read The Filing